Skip to Content
Opening Bell
News
BenzingaSeptember 14, 2026 at 2:29 AM NYLast Month

BTIG Reiterates Buy on Solventum, Maintains $95 Price Target

BTIG analyst Ryan Zimmerman reiterates Solventum (NYSE:SOLV) with a Buy and maintains $95 price target.

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga

Read at Source